The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...

A guide to our carefully selected picks for the top CBD oils for dogs in 2025 to soothe anxiety, pain and arthritis.

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...

FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast absorption for effective symptom control.

On a well-known rating scale that runs from 0 to 10, the study participants started with pain of about ... Vertex said that it has set a wholesale cost of $15.50 per 50-mg pill but that patient ...

“If the particulate matter enters the blood vessels, it can travel to various organs and potentially block blood vessels in the heart, lungs or brain, leading to serious complications such as stroke ...

only 8 mg syringes available from manufacturer Administered 10 mg (10 mg/mL) of morphine instead of 1 mg (1 mg/mL); patient required naloxone and was transferred to critical care Misfilled an ...